Joergen Drejer - Saniona AB CEO, Director

SANION Stock  SEK 1.78  0.02  1.11%   

CEO

Dr. Joergen Drejer, Ph.D. was Chief Executive Officer and Member of the Board of Directors at Saniona AB since 2014. He is Cofounder of the Company. He was a cofounder of NeuroSearch in 1989 serving as Executive Vice President and Research Director. He is a serial entrepreneur and also cofounded or assisted in founding several other biotech companies, including, NsGene, Sophion Biosciences, Antalium Poseidon Pharmaceuticals, and Azign. He was Board Member of Atonomics AS, Delta, NSGene AS, Origio AS, Poseidon Pharmaceuticals AS, Zgene AS and Aktieselskabet af 20. November 2003. He is Board Member and CEO of Saniona AS and Member of the Board of Directors at Ellegaard Gottingen Minipigs ApS and Azign Bioscience AS. He is the author of more than 75 peerreviewed articles and holds a Doctorate in Philosophy in Neurobiology from the Royal Danish School of Pharmacy . since 2014.
Age 61
Tenure 10 years
Professional MarksPh.D
Phone45 70 70 52 25
Webhttps://www.saniona.com

Saniona AB Management Efficiency

The company has return on total asset (ROA) of (0.5044) % which means that it has lost $0.5044 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.3844) %, meaning that it generated substantial loss on money invested by shareholders. Saniona AB's management efficiency ratios could be used to measure how well Saniona AB manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 92.97 M in total debt with debt to equity ratio (D/E) of 34.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Saniona AB has a current ratio of 1.26, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Saniona AB until it has trouble settling it off, either with new capital or with free cash flow. So, Saniona AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Saniona AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Saniona to invest in growth at high rates of return. When we think about Saniona AB's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

CEO Age

Hakan JeppssonInwido AB
54
Henrik BoreliusAttendo AB
45
Tormod GunleiksrudAlimak Hek Group
57
Henrik HjalmarssonInwido AB
47
Saniona AB , a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases, and treatment of pain in Denmark. Saniona AB was founded in 2011 and is headquartered in Ballerup, Denmark. Saniona AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 21 people. Saniona AB (SANION) is traded on Stockholm Exchange in Sweden and employs 25 people.

Management Performance

Saniona AB Leadership Team

Elected by the shareholders, the Saniona AB's board of directors comprises two types of representatives: Saniona AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Saniona. The board's role is to monitor Saniona AB's management team and ensure that shareholders' interests are well served. Saniona AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Saniona AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carl Sundberg, Independent Director
Leif Andersson, Independent Director
Edward Saltzman, Director
Claus Braestrup, Independent Chairman of the Board
Palle Christophersen, Co-Founder and Chief Scientific Officer
Janus Larsen, Chief Officer
deBethizy, Chairman of the Board
MBA MSc, CoFounder CEO
Thomas Feldthus, CFO, Executive Vice President
Joergen Drejer, CEO, Director
Jorgen Drejer, Chairman Founder
Karin Nielsen, Chief Officer
Rami Levin, President
Anker Lundemose, Independent Director
Palle MS, Ex Research
Anita BCom, Chief Officer
Anna Ljung, Director

Saniona Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Saniona AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Saniona AB in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Saniona AB's short interest history, or implied volatility extrapolated from Saniona AB options trading.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Saniona AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Saniona Stock analysis

When running Saniona AB's price analysis, check to measure Saniona AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Saniona AB is operating at the current time. Most of Saniona AB's value examination focuses on studying past and present price action to predict the probability of Saniona AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Saniona AB's price. Additionally, you may evaluate how the addition of Saniona AB to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Please note, there is a significant difference between Saniona AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if Saniona AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Saniona AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.